Current research on diphtheria toxin focuses on understanding its molecular structure and mechanism of action, which can provide insights into developing novel therapeutic interventions. Studies are also exploring ways to enhance vaccine efficacy and coverage to prevent outbreaks. The application of genetic and biotechnological approaches is being investigated to create recombinant toxins with reduced toxicity for potential use in cancer therapy.
